English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Glycophorins are the most abundant sialoglycoproteins on the surface of human erythrocyte membranes. Genetic variation in glycophorin region of human chromosome 4 (containing  GYPA ,  GYPB , and  GYPE  genes) is of interest because the gene products serve as receptors for pathogens of major public health interest, including  Plasmodium   sp. ,  Babesia   sp. , Influenza virus,  Vibrio cholerae  El Tor Hemolysin, and  Escherichia coli . A large structural rearrangement and hybrid glycophorin variant, known as  Dantu , which was identified in East African populations, has been linked with a 40% reduction in risk for severe malaria. Apart from  Dantu , other large structural variants exist, with the most common being deletion of the whole  GYPB  gene and its surrounding region, resulting in multiple different deletion forms. In West Africa particularly, these deletions are estimated to account for between 5 and 15% of the variation in different populations, mostly attributed to the forms known as DEL1 and DEL2. Due to the lack of specific variant assays, little is known of the distribution of these variants. Here, we report a modification of a previous  GYPB  DEL1 assay and the development of a novel  GYPB  DEL2 assay as high-throughput PCR-RFLP assays, as well as the identification of the crossover/breakpoint for  GYPB  DEL2. Using 393 samples from three study sites in Ghana as well as samples from HapMap and 1000 G projects for validation, we show that our assays are sensitive and reliable for genotyping  GYPB  DEL1 and DEL2. To the best of our knowledge, this is the first report of such high-throughput genotyping assays by PCR-RFLP for identifying specific  GYPB  deletion types in populations. These assays will enable better identification of GYPB deletions for large genetic association studies and functional experiments to understand the role of this gene cluster region in susceptibility to malaria and other diseases.

High-throughput genotyping assays for identification of glycophorin B deletion variants in population studies